Study S002697

Prospective, Single Center, Open-label Study Assessing Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality and Biomarkers in Patients on Glucagon-like Peptide-1 Agonists

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07221461
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 24
Start: 2025-11-01
Primary completion: 2026-01-30
Lead sponsor: Goldman, Butterwick, Fitzpatrick and Groff
Conditions: Wrinkle
Interventions: DEVICE:Skinvive
Results posted: FALSE

Registered primary outcomes

Global Fine Lines [Screening, Day 30, Day 60]
Overall Hyperpigmentation [Screening, Day 30, Day 60]
Skin Tone Evenness [Screening, Day 30, Day 60]
Skin Firmness [Screening, Day 30, Day 60]
Skin Radiance/ Brightness [Screening, Day 30, Day 60]
Skin Texture Smoothness [Screening, Day 30, Day 60]
Global Wrinkles [Screening, Day 30, Day 60]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.